Nevertheless, these data raised the possibility that for patients with NSCLC, those with higher expression of hub genes might be “immunoactive”, have higher expression of immune checkpoints, and a higher CD4 memory activated and CD8 T cell repertoire, and they might be more sensitive to ICIs. The gene discussed is CD4; the disease is non-small cell lung carcinoma.